개인구독
소속 기관이 없으신 경우, 개인 정기구독을 하시면 저렴하게
논문을 무제한 열람 이용할 수 있어요.
지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2022.4
- 수록면
- 241 - 248 (8page)
- DOI
- http://dx.doi.org/10.5124/jkma.2022.65.4.241
이용수
초록· 키워드
오류제보하기
Background: Osteoporosis is a skeletal disorder characterized by compromised bone strength resulting in a predisposition to fracture. Osteoporosis-related fractures can lead to pain, disability, and increased healthcare costs. We aimed to explore the guidelines and criteria for selecting medications for osteoporosis.
Current Concepts: Osteoporosis medications can be classified mainly as antiresorptive drugs and osteogenesis promoters. The former includes selective estrogen receptor modulators, bisphosphonates, and receptor activators of nuclear factor kappa-B ligand inhibitors, e.g., denosumab. The latter includes human parathyroid hormone, e.g., teriparatide, and the dual-action agent, romosozumab. Selective estrogen receptor modulators (raloxifene or bazedoxifene) can be considered suitable for younger postmenopausal women with low spine bone mineral density. It also can be used for patients with low glomerular filtration rates due to low excretion in urine and patients who need dental care. Bisphosphonate has a residual effect on bone; therefore, osteonecrosis of the jaw and atypical fractures should be considered as side effects for its long-term use. Presently, denosumab is the most potent antiresorptive agent, but its favorable skeletal effects can be reversed quickly after its cessation. Therefore, subsequent antiresorptive treatment is mandatory. Romosozumab is a dual-action agent that simultaneously stimulates bone formation and inhibits bone resorption. It also needs a subsequent antiresorptive treatment.
Discussion and Conclusion: Tailored treatment is needed in a patient with osteoporosis. Even in the case of the same bone density, the risk of fracture and the fracture sites differ depending on age. After setting an achievable goal of bone density within a suitable period, the appropriate medication should be selected.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
New Antiresorptive Therapies for Postmenopausal Osteoporosis
대한폐경학회지
2015 .01
-
RANKL 억제제의 최신 업데이트
대한내과학회지
2018 .01
-
New treatments of osteoporosis
Osteoporosis and Sarcopenia
2015 .01
-
Nonsurgical Treatment Strategies after Osteoporotic Hip Fractures
Hip and Pelvis
2015 .01
-
Medical treatment of severe osteoporosis including new concept of advanced severe osteoporosis
Osteoporosis and Sarcopenia
2016 .01
-
A coordination project for improvement of osteoporosis medication use among patients who sustained osteoporotic fracture(s)
Osteoporosis and Sarcopenia
2019 .01
-
Environmental Air Pollution and the Risk of Osteoporosis and Bone Fractures
예방의학회지
2018 .01
-
Environmental Air Pollution and the Risk of Osteoporosis and Bone Fractures
예방의학회지
2018 .01
-
Factors associated with osteoporosis medication initiation and adherence
Osteoporosis and Sarcopenia
2018 .01
-
건강보험 청구자료를 이용한 골다공증 치료제의 처방 양상과 골형성촉진제 처방에 미치는 영향요인
한국임상약학회지
2021 .01
-
남성 골다공증의 위험 요인에 대한 최신 지견과 공중보건학적 중재 전략
보건교육건강증진학회지
2023 .06
-
Factors affecting bone mineral density in children and adolescents with secondary osteoporosis
Annals of Pediatirc Endocrinology & Metabolism
2023 .03
-
Surgical treatment of severe osteoporosis including new concept of advanced severe osteoporosis
Osteoporosis and Sarcopenia
2017 .01
-
Introduction of the Cost-Effectiveness Studies of Fracture Liaison Service in Other Countries
대한골대사학회지
2020 .01
-
Operationalizing Treat-to-Target for Osteoporosis
Endocrinology and Metabolism
2021 .01
-
Effectiveness of Osteoporosis Drug in Postmenopausal Women with Spinal Compression Fracture: Combined Consecutive Therapy of Teriparatide and Raloxifene versus Bisphosphonate Single
Korean Journal of Neurotrauma
2016 .01
-
Compliance and discontinuation of denosumab treatment in postmenopausal Japanese women with primary osteoporosis or rheumatoid arthritis and osteoporosis
Osteoporosis and Sarcopenia
2017 .01
-
Up-to-Date Knowledge on Osteoporosis Treatment Selection in Postmenopausal Women
대한폐경학회지
2022 .12
-
Asia-Pacific consensus on long-term and sequential therapy for osteoporosis
Osteoporosis and Sarcopenia
2024 .03
-
Persistence with Denosumab in Male Osteoporosis Patients: A Real-World, Non-Interventional Multicenter Study
Endocrinology and Metabolism
2023 .04
이 논문의 저자 정보
최근 본 자료
댓글(0)
0